WO2004050070A3 - Producto farmaceutico para aliviar o hacer desaparecer los ronquidos de un roncador moderado o severo - Google Patents

Producto farmaceutico para aliviar o hacer desaparecer los ronquidos de un roncador moderado o severo Download PDF

Info

Publication number
WO2004050070A3
WO2004050070A3 PCT/IB2003/005652 IB0305652W WO2004050070A3 WO 2004050070 A3 WO2004050070 A3 WO 2004050070A3 IB 0305652 W IB0305652 W IB 0305652W WO 2004050070 A3 WO2004050070 A3 WO 2004050070A3
Authority
WO
WIPO (PCT)
Prior art keywords
domperidone
pseudoephedrine
composition
preventing snoring
snoring
Prior art date
Application number
PCT/IB2003/005652
Other languages
English (en)
French (fr)
Other versions
WO2004050070A2 (es
Inventor
Orrego Augusto Larrain
Original Assignee
Orrego Augusto Larrain
Morri Francesca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orrego Augusto Larrain, Morri Francesca filed Critical Orrego Augusto Larrain
Priority to JP2004556696A priority Critical patent/JP2006509784A/ja
Priority to CA2508250A priority patent/CA2508250C/en
Priority to EP03777040A priority patent/EP1570844B1/en
Priority to AU2003286297A priority patent/AU2003286297A1/en
Priority to US10/536,549 priority patent/US7718191B2/en
Priority to DE60310126T priority patent/DE60310126T2/de
Publication of WO2004050070A2 publication Critical patent/WO2004050070A2/es
Publication of WO2004050070A3 publication Critical patent/WO2004050070A3/es
Priority to IL168851A priority patent/IL168851A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invencion se refiere al nuevo use de un producto farmaceutico compuesto por la combinacion de las sustancias pseudofedrina sulfato y domperidona, util para aliviar o hacer desaparecer los ronquidos de un ronqueador moderado o severo.
PCT/IB2003/005652 2002-11-12 2003-12-01 Producto farmaceutico para aliviar o hacer desaparecer los ronquidos de un roncador moderado o severo WO2004050070A2 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2004556696A JP2006509784A (ja) 2002-12-02 2003-12-01 中程度または重症のいびきを軽減させるかまたは治癒させるための医薬品
CA2508250A CA2508250C (en) 2002-12-02 2003-12-01 Pharmaceutical product that aims to alleviate or cure the snoring of a moderate or severe snorer
EP03777040A EP1570844B1 (en) 2002-12-02 2003-12-01 Composition comprising pseudoephedrine and domperidone for preventing snoring
AU2003286297A AU2003286297A1 (en) 2002-12-02 2003-12-01 Composition comprising pseudoephedrine and domperidone for preventing snoring
US10/536,549 US7718191B2 (en) 2002-12-02 2003-12-01 Pharmaceutical product which is used to reduced or stop moderate or severe snoring
DE60310126T DE60310126T2 (de) 2002-12-02 2003-12-01 Zusammensetzung enthaltend pseudoephedrin und domperidone zum verhindern des schnarchens
IL168851A IL168851A (en) 2002-11-12 2005-05-29 Composition comprising pseudoephedrine and domperidone for preventing snoring

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CL2760/2002 2002-12-02
CL2002002760 2002-12-02

Publications (2)

Publication Number Publication Date
WO2004050070A2 WO2004050070A2 (es) 2004-06-17
WO2004050070A3 true WO2004050070A3 (es) 2004-07-29

Family

ID=37122881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/005652 WO2004050070A2 (es) 2002-11-12 2003-12-01 Producto farmaceutico para aliviar o hacer desaparecer los ronquidos de un roncador moderado o severo

Country Status (10)

Country Link
US (1) US7718191B2 (es)
EP (1) EP1570844B1 (es)
JP (1) JP2006509784A (es)
CN (1) CN1726036A (es)
AR (1) AR042259A1 (es)
AU (1) AU2003286297A1 (es)
CA (1) CA2508250C (es)
DE (1) DE60310126T2 (es)
ES (1) ES2278208T3 (es)
WO (1) WO2004050070A2 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FIREMAN P: "THERAPEUTIC APPROACHES TO ALLERGIC RHINITIS: TREATING THE CHILD", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY - YEARLY BOOK, INC, US, vol. 105, no. 6, 2000, pages S616 - S621, XP001097923, ISSN: 0091-6749 *

Also Published As

Publication number Publication date
AU2003286297A8 (en) 2004-06-23
AR042259A1 (es) 2005-06-15
JP2006509784A (ja) 2006-03-23
AU2003286297A1 (en) 2004-06-23
EP1570844A2 (en) 2005-09-07
DE60310126T2 (de) 2007-09-20
WO2004050070A2 (es) 2004-06-17
CA2508250C (en) 2011-06-21
US7718191B2 (en) 2010-05-18
EP1570844B1 (en) 2006-11-29
US20060233872A1 (en) 2006-10-19
DE60310126D1 (de) 2007-01-11
CA2508250A1 (en) 2004-06-17
CN1726036A (zh) 2006-01-25
ES2278208T3 (es) 2007-08-01

Similar Documents

Publication Publication Date Title
IL164003A (en) Sulfonylamino-derivatives, compositions thereof, process of preparation and uses for the manufacture of medicaments for inhibiting histone deacetylase
AU2003257666A1 (en) COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
AU2003235613A1 (en) Crude drug compositions for treating or preventing arthritic diseases and the preparation process
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
IL203923A (en) Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
HUP0402566A3 (en) C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them
WO2004006858A3 (en) Compounds, compositions, and methods employing same
AU2003205472A1 (en) Gaskets and other products obtained by co-dispensed compositions
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
WO2004041269A3 (en) New use for pharmaceutical composition
WO2003087050A3 (fr) Sel de perindopril et les compositions pharmaceutiques qui le contiennent
AU2003220361A1 (en) Benzamides and compositions benzamides for use as fungizide
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
IL167187A (en) Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
EP1550448A4 (en) HISTAMINE RELEASE INHIBITORS
IL209789A0 (en) Metabolites of 3-(2-dimethylaminomethyl-cyclohexyl)- phenol, pharmaceutical compositions comprising the same and uses thereof
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2001278821A1 (en) Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
WO2005110413A3 (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
WO2003020963A3 (en) Proteins in type 2 diabetes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 168851

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2004556696

Country of ref document: JP

Ref document number: 2508250

Country of ref document: CA

Ref document number: 2322/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 20038A58832

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2003777040

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003777040

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006233872

Country of ref document: US

Ref document number: 10536549

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10536549

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2003777040

Country of ref document: EP